George A. Chressanthis

The coronavirus is likely to have an economic impact on the pharma industry, but how bad will it be?

Is the pharma industry ready for another recession?

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Pharma needs new business model designs and analytics to help measure value.

Evidence suggests that price controls could hamper innovation and negatively affect patient health outcomes.